EsoBiotec Doses First Patient in Investigator Initiated Trial of In Vivo BCMA CAR-T Candidate ESO-T01 for Multiple Myeloma
Initial clinical observations suggest high level of T cells reprogramming and CAR-T expansion at the starting dose without lymphodepletion At 28 ...
2 of the largest stock photo platforms are merging, sending their shares up
The combined company, which will be called Getty Images, will be worth $3.7 billion, Getty said on Tuesday.